| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.26 | 4e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |